Literature DB >> 26092858

Comparison of the Pathogenesis of the Angola and Ravn Strains of Marburg Virus in the Outbred Guinea Pig Model.

Robert W Cross1, Karla A Fenton1, Joan B Geisbert1, Hideki Ebihara2, Chad E Mire1, Thomas W Geisbert1.   

Abstract

BACKGROUND: Phylogenetic comparisons of known Marburg virus (MARV) strains reveal 2 distinct genetic lineages: Ravn and the Lake Victoria Marburg complex (eg, Musoke, Popp, and Angola strains). Nucleotide variances of >20% between Ravn and other MARV genomes suggest that differing virulence between lineages may accompany this genetic divergence. To date, there exists limited systematic experimental evidence of pathogenic differences between MARV strains.
METHODS: Uniformly lethal outbred guinea pig models of MARV-Angola (MARV-Ang) and MARV-Ravn (MARV-Rav) were developed by serial adaptation. Changes in genomic sequence, weight, temperature, histopathologic findings, immunohistochemical findings, hematologic profiles, circulating biochemical enzyme levels, coagulation parameters, viremia levels, cytokine levels, eicanosoid levels, and nitric oxide production were compared between strains.
RESULTS: MARV-Rav infection resulted in delayed increases in circulating inflammatory and prothrombotic elements, notably lower viremia levels, less severe histologic alterations, and a delay in mean time to death, compared with MARV-Ang infection. Both strains produced more marked coagulation abnormalities than previously seen in MARV-infected mice or inbred guinea pigs.
CONCLUSIONS: Although both strains exhibit great similarity to pathogenic markers of human and nonhuman primate MARV infection, these data highlight several key differences in pathogenicity that may serve to guide the choice of strain and model used for development of vaccines or therapeutics for Marburg hemorrhagic fever. Published by Oxford University Press on behalf of the Infectious Diseases Society of America 2015. This work is written by (a) US Government employee(s) and is in the public domain in the US.

Entities:  

Keywords:  Angola; Marburg virus; Ravn; animal model; coagulation; filovirus; guinea pig; pathogenesis

Mesh:

Substances:

Year:  2015        PMID: 26092858      PMCID: PMC4564542          DOI: 10.1093/infdis/jiv182

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  31 in total

1.  Cross-protection against Marburg virus strains by using a live, attenuated recombinant vaccine.

Authors:  Kathleen M Daddario-DiCaprio; Thomas W Geisbert; Joan B Geisbert; Ute Ströher; Lisa E Hensley; Allen Grolla; Elizabeth A Fritz; Friederike Feldmann; Heinz Feldmann; Steven M Jones
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

2.  Apoptosis induced in vitro and in vivo during infection by Ebola and Marburg viruses.

Authors:  T W Geisbert; L E Hensley; T R Gibb; K E Steele; N K Jaax; P B Jahrling
Journal:  Lab Invest       Date:  2000-02       Impact factor: 5.662

3.  VP24 of Marburg virus influences formation of infectious particles.

Authors:  Sandra Bamberg; Larissa Kolesnikova; Peggy Möller; Hans-Dieter Klenk; Stephan Becker
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

4.  Marburg hemorrhagic fever in Durba and Watsa, Democratic Republic of the Congo: clinical documentation, features of illness, and treatment.

Authors:  Robert Colebunders; Antoine Tshomba; Maria D Van Kerkhove; Daniel G Bausch; Pat Campbell; Modeste Libande; Patricia Pirard; Florimond Tshioko; Simon Mardel; Sabue Mulangu; Hilde Sleurs; Pierre E Rollin; Jean-Jacques Muyembe-Tamfum; Benjamin Jeffs; Matthias Borchert
Journal:  J Infect Dis       Date:  2007-11-15       Impact factor: 5.226

5.  Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection.

Authors:  Thomas W Geisbert; Lisa E Hensley; Tom Larsen; Howard A Young; Douglas S Reed; Joan B Geisbert; Dana P Scott; Elliott Kagan; Peter B Jahrling; Kelly J Davis
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

6.  Monovalent virus-like particle vaccine protects guinea pigs and nonhuman primates against infection with multiple Marburg viruses.

Authors:  Dana L Swenson; Kelly L Warfield; Tom Larsen; D Anthony Alves; Sadie S Coberley; Sina Bavari
Journal:  Expert Rev Vaccines       Date:  2008-05       Impact factor: 5.217

7.  Genomic differences between guinea pig lethal and nonlethal Marburg virus variants.

Authors:  Loreen L Lofts; M Sofi Ibrahim; Diane L Negley; Michael C Hevey; Alan L Schmaljohn
Journal:  J Infect Dis       Date:  2007-11-15       Impact factor: 5.226

8.  Development and characterization of a mouse model for Marburg hemorrhagic fever.

Authors:  Kelly L Warfield; Steven B Bradfute; Jay Wells; Loreen Lofts; Meagan T Cooper; D Anthony Alves; Daniel K Reed; Sean A VanTongeren; Christine A Mech; Sina Bavari
Journal:  J Virol       Date:  2009-04-15       Impact factor: 5.103

9.  Recombinant Marburg viruses containing mutations in the IID region of VP35 prevent inhibition of Host immune responses.

Authors:  César G Albariño; Lisa Wiggleton Guerrero; Jessica R Spengler; Luke S Uebelhoer; Ayan K Chakrabarti; Stuart T Nichol; Jonathan S Towner
Journal:  Virology       Date:  2014-12-19       Impact factor: 3.616

10.  Marburg virus Angola infection of rhesus macaques: pathogenesis and treatment with recombinant nematode anticoagulant protein c2.

Authors:  Thomas W Geisbert; Kathleen M Daddario-DiCaprio; Joan B Geisbert; Howard A Young; Pierre Formenty; Elizabeth A Fritz; Tom Larsen; Lisa E Hensley
Journal:  J Infect Dis       Date:  2007-11-15       Impact factor: 5.226

View more
  27 in total

1.  Marburg and Ravn Virus Infections Do Not Cause Observable Disease in Ferrets.

Authors:  Gary Wong; Zirui Zhang; Shihua He; Marc-Antoine de La Vega; Kevin Tierney; Geoff Soule; Kaylie Tran; Lisa Fernando; Xiangguo Qiu
Journal:  J Infect Dis       Date:  2018-11-22       Impact factor: 5.226

2.  A Recombinant Rabies Virus Expressing the Marburg Virus Glycoprotein Is Dependent upon Antibody-Mediated Cellular Cytotoxicity for Protection against Marburg Virus Disease in a Murine Model.

Authors:  Rohan Keshwara; Katie R Hagen; Tiago Abreu-Mota; Amy B Papaneri; David Liu; Christoph Wirblich; Reed F Johnson; Matthias J Schnell
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

3.  Considerations in the Use of Nonhuman Primate Models of Ebola Virus and Marburg Virus Infection.

Authors:  Thomas W Geisbert; James E Strong; Heinz Feldmann
Journal:  J Infect Dis       Date:  2015-06-10       Impact factor: 5.226

4.  Natural History and Pathogenesis of Wild-Type Marburg Virus Infection in STAT2 Knockout Hamsters.

Authors:  Colm Atkins; Jinxin Miao; Birte Kalveram; Terry Juelich; Jennifer K Smith; David Perez; Lihong Zhang; Jonna L B Westover; Arnaud J Van Wettere; Brian B Gowen; Zhongde Wang; Alexander N Freiberg
Journal:  J Infect Dis       Date:  2018-11-22       Impact factor: 5.226

5.  VP24-Karyopherin Alpha Binding Affinities Differ between Ebolavirus Species, Influencing Interferon Inhibition and VP24 Stability.

Authors:  Toni M Schwarz; Megan R Edwards; Audrey Diederichs; Joshua B Alinger; Daisy W Leung; Gaya K Amarasinghe; Christopher F Basler
Journal:  J Virol       Date:  2017-01-31       Impact factor: 5.103

6.  Ferrets Infected with Bundibugyo Virus or Ebola Virus Recapitulate Important Aspects of Human Filovirus Disease.

Authors:  Robert Kozak; Shihua He; Andrea Kroeker; Marc-Antoine de La Vega; Jonathan Audet; Gary Wong; Chantel Urfano; Kym Antonation; Carissa Embury-Hyatt; Gary P Kobinger; Xiangguo Qiu
Journal:  J Virol       Date:  2016-09-29       Impact factor: 5.103

Review 7.  A Forgotten Episode of Marburg Virus Disease: Belgrade, Yugoslavia, 1967.

Authors:  Elizabeta S Ristanović; Nenad S Kokoškov; Ian Crozier; Jens H Kuhn; Ana S Gligić
Journal:  Microbiol Mol Biol Rev       Date:  2020-05-13       Impact factor: 11.056

Review 8.  Post-exposure treatments for Ebola and Marburg virus infections.

Authors:  Robert W Cross; Chad E Mire; Heinz Feldmann; Thomas W Geisbert
Journal:  Nat Rev Drug Discov       Date:  2018-01-29       Impact factor: 84.694

Review 9.  Rodent-Adapted Filoviruses and the Molecular Basis of Pathogenesis.

Authors:  Logan Banadyga; Michael A Dolan; Hideki Ebihara
Journal:  J Mol Biol       Date:  2016-05-14       Impact factor: 5.469

Review 10.  Neglected filoviruses.

Authors:  Robin Burk; Laura Bollinger; Joshua C Johnson; Jiro Wada; Sheli R Radoshitzky; Gustavo Palacios; Sina Bavari; Peter B Jahrling; Jens H Kuhn
Journal:  FEMS Microbiol Rev       Date:  2016-06-05       Impact factor: 16.408

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.